Marcus S. Delatte

448 total citations
21 papers, 343 citations indexed

About

Marcus S. Delatte is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Marcus S. Delatte has authored 21 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 8 papers in Pharmacology and 6 papers in Molecular Biology. Recurrent topics in Marcus S. Delatte's work include Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Cannabis and Cannabinoid Research (7 papers). Marcus S. Delatte is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Cannabis and Cannabinoid Research (7 papers). Marcus S. Delatte collaborates with scholars based in United States, Belgium and Netherlands. Marcus S. Delatte's co-authors include Johannes W. Von den Hoff, Jack Bergman, Kiran Vemuri, Ganesh A. Thakur, Peter J. Winsauer, Joseph M. Moerschbaecher, Carol A. Paronis, Anne Marie Kuijpers‐Jagtman, Jaap C. Maltha and A. Makriyannis and has published in prestigious journals such as The FASEB Journal, Pharmacological Reviews and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Marcus S. Delatte

19 papers receiving 330 citations

Peers

Marcus S. Delatte
Nicole A. Northrop United States
Gisela Eckel Germany
Marta Bryk Poland
Lawrence M. Carey United States
Madhu Shivakumar United States
Nicole A. Northrop United States
Marcus S. Delatte
Citations per year, relative to Marcus S. Delatte Marcus S. Delatte (= 1×) peers Nicole A. Northrop

Countries citing papers authored by Marcus S. Delatte

Since Specialization
Citations

This map shows the geographic impact of Marcus S. Delatte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus S. Delatte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus S. Delatte more than expected).

Fields of papers citing papers by Marcus S. Delatte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus S. Delatte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus S. Delatte. The network helps show where Marcus S. Delatte may publish in the future.

Co-authorship network of co-authors of Marcus S. Delatte

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus S. Delatte. A scholar is included among the top collaborators of Marcus S. Delatte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus S. Delatte. Marcus S. Delatte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Authier, Simon, Marcus S. Delatte, Wendy Halpern, et al.. (2025). Toxicology and safety pharmacology investigations on the nervous system: 2024 industry survey. Journal of Pharmacological and Toxicological Methods. 135. 108378–108378.
2.
Sokolowski, Katie, et al.. (2025). Identifying and Understanding Seizure Liability in Drug Development. International Journal of Toxicology. 44(2). 99–124.
3.
Murray, Conor H., Brenda M. Gannon, Peter J. Winsauer, Ziva D. Cooper, & Marcus S. Delatte. (2024). The Development of Cannabinoids as Therapeutic Agents in the United States. Pharmacological Reviews. 76(5). 915–955. 4 indexed citations
4.
Barnett, Brian S., Marcus S. Delatte, Franklin King, et al.. (2024). Practical considerations in the establishment of psychedelic research programs. Psychopharmacology. 242(1). 27–43. 8 indexed citations
5.
Sokolowski, Katie, et al.. (2024). The Role of Neuropathology Evaluation in the Nonclinical Assessment of Seizure Liability. Toxicologic Pathology. 52(8). 566–573. 1 indexed citations
6.
Authier, Simon, et al.. (2016). EEG in non-clinical drug safety assessments: Current and emerging considerations. Journal of Pharmacological and Toxicological Methods. 81. 274–285. 16 indexed citations
7.
Authier, Simon, Joseph C. Arezzo, Marcus S. Delatte, et al.. (2016). Safety pharmacology investigations on the nervous system: An industry survey. Journal of Pharmacological and Toxicological Methods. 81. 37–46. 61 indexed citations
8.
Kangas, Brian D., Marcus S. Delatte, Kiran Vemuri, et al.. (2013). Cannabinoid Discrimination and Antagonism by CB1 Neutral and Inverse Agonist Antagonists. Journal of Pharmacology and Experimental Therapeutics. 344(3). 561–567. 43 indexed citations
10.
Hoff, Johannes W. Von den & Marcus S. Delatte. (2008). Interplay of mechanical loading and growth factors in the mandibular condyle. Archives of Oral Biology. 53(8). 709–715. 24 indexed citations
11.
Delatte, Marcus S. & Carol A. Paronis. (2007). Evaluation of cannabinoid agonists using punished responding and midazolam discrimination procedures in squirrel monkeys. Psychopharmacology. 198(4). 521–528. 4 indexed citations
12.
Bergman, Jack, Marcus S. Delatte, Carol A. Paronis, et al.. (2007). Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties. Physiology & Behavior. 93(4-5). 666–670. 54 indexed citations
14.
Delatte, Marcus S., Johannes W. Von den Hoff, & Anne Marie Kuijpers‐Jagtman. (2005). Regulatory effects of FGF-2 on the growth of mandibular condyles and femoral heads from newborn rats. Archives of Oral Biology. 50(11). 959–969. 4 indexed citations
15.
Winsauer, Peter J., et al.. (2004). Effects of MDMA administration on scopolamine-induced disruptions of learning and performance in rats. Pharmacology Biochemistry and Behavior. 79(3). 459–472. 7 indexed citations
16.
Delatte, Marcus S., Johannes W. Von den Hoff, Jaap C. Maltha, & Anne Marie Kuijpers‐Jagtman. (2003). Growth stimulation of mandibular condyles and femoral heads of newborn rats by IGF-I. Archives of Oral Biology. 49(3). 165–175. 39 indexed citations
17.
Winsauer, Peter J., Una D. McCann, Marcus S. Delatte, et al.. (2002). Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration. Psychopharmacology. 159(4). 388–396. 21 indexed citations
18.
Delatte, Marcus S., Peter J. Winsauer, & Joseph M. Moerschbaecher. (2002). Tolerance to the disruptive effects of Δ9-THC on learning in rats. Pharmacology Biochemistry and Behavior. 74(1). 129–140. 19 indexed citations
19.
Winsauer, Peter J., et al.. (2002). Effects of triazolam, 8-OH-DPAT, and buspirone on repeated acquisition in squirrel monkeys.. Experimental and Clinical Psychopharmacology. 10(4). 392–399. 3 indexed citations
20.
Winsauer, Peter J., et al.. (2002). Effects of triazolam, 8-OH-DPAT, and buspirone on repeated acquisition in squirrel monkeys.. Experimental and Clinical Psychopharmacology. 10(4). 392–399. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026